Search Results
Results found for "Chun-Chun Chang"
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
This makes it an ideal candidate for GPCR research, where accuracy in detecting subtle signaling changes
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
GPCRs has well‑known limitations—fixation artifacts, epitope masking, low expression, conformation changes
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
This paper thoroughly investigated the role of single amino acid changes to clarify the molecular mechanisms
- How to Avoid the Most Common Gaps in Your Biotech Pitch
What Changes When Your Pitch Works When your biotech pitch lands, the difference is immediate and powerful
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
Here, we show the conformational changes for βarr activation upon the C tail- and TM core-mediated interactions
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
That shift changes everything.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Guo, W., et al., Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
This strategy accelerated discovery and reduced noise, helping them understand how each design change
- Phospholipid Scrambling by G Protein-Coupled Receptors
Conformational changes that facilitate scrambling are distinct from those associated with GPCR signaling
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
What is changing is the focus.
- 📰 GPCR Weekly News, April 1 to 7, 2024
Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook Sosei Heptares officially changed
- 📰 GPCR Weekly News, May 15 to 21, 2023
Take the chance to contribute to this exciting event! For Dr. GPCRs in Oncology and Immunology Stable Binding of Full-Length Chemerin is Driven by Negative Charges
- From Failed Experiments to Predictive GPCR Models
to pursue a thesis at Scripps Research in San Diego, where he focused on how proteins respond to pH changes
- 📰 GPCR Weekly News, March 4 to 10, 2024
from March 4th to 10th, 2024 GPCR Activation and Signaling Glu1022.53-Mediated Early Conformational Changes
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
Structural analysis of SMO domains shows significant changes in the CRD and ICD, during the course of
- GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between ...
molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated changes
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
In all cases, the receptor interaction changes downstream signalling and the responses to receptor agonists
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
This is your chance to get ahead of the curve.
- 📰 GPCR Weekly News, February 5 to 11, 2024
cAMP signaling in the Hedgehog pathway Unraveling the Interplay of Extracellular Domain Conformational Changes
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, September 18 to 24, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, September 11 to 17, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Here, we investigate the conformational changes induced by the binding of a nanobody (Nb80) on the active-like
- 📰 GPCR Weekly News, August 28 to September 3, 2023
Drug Targets: Allosteric Function and Biased Signaling" at the DOT NEW October 3, 2023 | FREE Seminar: Changing
- 📰 GPCR Weekly News, June 17 to 23, 2024
mechanotransduction at endothelial junctions GPCRs in Neuroscience Male-specific behavioral and transcriptomic changes
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Allostery of G-Protein-Coupled Receptors Industry News Sosei Heptares to take back GPCR agonist after GSK changes
- Ever Wondered How Drugs Are Discovered?
Don’t miss your chance to learn from one of the best: Unlock “Introduction to Drug Discovery" now
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Xiaoyu Zhang showed great insight into new ligands for new E3 ligases for PROTAC development. This was a very enriching experience for Maria, not only did she have a chance to share Celtarys’ technology She also took the chance to do some sightseeing in Chicago .
- 📰 GPCR Weekly News, March 6 to 12, 2023
de l'Innovation Technologique (Technological Innovation Award) Sosei Heptares Receives Approval for Change
- Knowing When to Walk, Knowing When to Run: Lessons from the Bench
Crazy Idea When a collaborator offered a neuroma model (one where opioids usually fail), Ben took a chance












